Torsade de pointes caused by hydroxychloroquine use in a patient with a severe form of COVID-19
| Autor: | Fouzia Douirek, Youssef Zarrouki, M.A. Samkaoui, Houssam Rebahi, M. Rhezali, A. Ziad |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2023 |
| Předmět: |
Multiple abnormalities
medicine.medical_specialty Cardiotoxicity 2019-20 coronavirus outbreak Coronavirus disease 2019 (COVID-19) Critically ill business.industry Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Hydroxychloroquine Critical Care and Intensive Care Medicine medicine.disease medicine Intensive care medicine business medicine.drug |
| Zdroj: | Southern African Journal of Critical Care; Vol. 36 No. 1 (2020); 12-13 |
| ISSN: | 1562-8264 2078-676X |
| Popis: | We report the case of a previously healthy patient who was severely affected by COVID-19 and developed torsade de pointes after hydroxychloroquine-azithromycin administration. Critically ill COVID-19 patients have multiple abnormalities that lead to an unsteady state in heart electricity, and can potentiate hydroxychloroquine cardiotoxicity. In light of this clinical observation, and until the efficacy of this association is proven, we plead against its use in critically ill COVID-19 patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|